SOUTH PLAINFIELD, N.J.--(BUSINESS WIRE)--Prolong Pharmaceuticals, LLC (the Company), a clinical-stage biopharmaceutical company, announced that it will present new clinical data from HEMERA-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback